News archive 2005
CMR ICIS publication: Sterol investments on the rise
In CMR ICIS publication 11-17 April 2005 (page 24) Doris de Guzman wrote on Forchem inter alia the following:
Sterol investments on the rise
STRONG SALES growth in heart-benefit foods is pushing phytosterols back into the limelight. Both the European and US markets have seen a flurry of plant expansions, joint ventures and new players, driven by recent health claims and regulatory approvals of phytosterol ingredients for use in several food applications.
Finnish tall-oil manufacturer Forchem Oy, plans to construct a €40 million ($53 million) sterol facility at its Rauma production site. The facility will be one of the largest plant sterol processing units in the world, with capacity of 4,000 to 6,000 tons annully. Completion of the project is slated for the second half of 2007.
“Some new capacities will come to the market in the coming years to meet the organic growth, but our estimate is that these are more of a debottlenecking of existing plants than new facilities” notes Hannu Näsi, senior vice president, business development, finance and administration, Forchem. “The investment will create relatively big new sterol volume to the fast-expanding market.”
In Europe, sterols demand is expected to increase by 15 percent per year by 2010, notes Forchem. The company says it will market its tall-oil-based sterol products to the food industry worldwide”.
In her article Doris de Guzman also describes international sterol markets, referring to famous companies like P&G, Forbes Medi-Tech and Raisio.